BCL3 and systemic lupus erythematosus: Also, in the context of systemic lupus erythematosus (SLE)–like disease, Bcl‐3 was shown to play a protective role, since Bcl3‐deficient mice carrying the lpr mutation developed a more severe SLE–like inflammatory phenotype than control lpr mice [119].